EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circadian rhythm disruption-related genes as potential diagnostic biomarkers in diabetic nephropathy: Integrated transcriptomic, single-nucleus, and molecular docking analyses

Min Zhou, Xuan Chen, Min Chen, Jinwen Zhao

Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100605

DOI: 10.1016/j.lddd.2026.100605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Min Zhou und 3 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic nephropathy (DN) is a major microvascular complication of diabetes. Circadian rhythm disruption (CRD) has been implicated in DN, but CRD-related diagnostic biomarkers and their underlying biological relevance remain incompletely understood.

Objectives

This study aimed to identify CRD-related candidate diagnostic biomarkers for DN, characterize their cellular distribution and in vitro functional relevance, and computationally explore potential compounds associated with the selected target.

Methods

DN transcriptomic datasets were obtained from the Gene Expression Omnibus (GEO) database. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were performed to identify CRD-related genes. Protein-protein interaction (PPI) network analysis and cross-dataset expression comparison were used to screen hub genes and construct a diagnostic model. Immune infiltration and single-nucleus analyses were conducted to investigate their potential biological relevance and cellular distribution. The expression and functional effects of the hub genes on high glucose-treated HK-2 cells were examined. Molecular docking and molecular dynamics simulations were employed to evaluate the potential interaction between Grapiprant and CXCR4 .

Results

ICAM1, CCL20 and CXCR4 were identified as candidate diagnostic biomarkers and integrated into a diagnostic model, which achieved an AUC of 0.896 in GSE142153 and an exploratory AUC of 0.958 in GSE30529. Because GSE30529 contributed to candidate-gene selection, the latter estimate was not considered independent external validation. The hub genes were associated with immune cell scores and the pathways related to TGF-β signaling, inflammation, and apoptosis. In vitro experiments confirmed their altered expression and functional relevance in high glucose-treated HK-2 cells. Single-nucleus analysis identified nine major cell clusters and revealed relatively elevated CXCR4 expression in the annotated plasma cell subset. Molecular docking and molecular dynamics simulations predicted a potential interaction between Grapiprant and CXCR4 .

Conclusions

ICAM1, CCL20 and CXCR4 may serve as CRD-related candidate diagnostic biomarkers for DN. However, these findings were limited by the small sample size in the public cohorts, lack of direct circadian rhythm measurements and independent tissue-level validation, and the computational nature of the predicted Grapiprant- CXCR4 interaction. Therefore, further validation in larger cohorts and experimental models is required.

Zitieren

APA

Zhou, M., Chen, X., Chen, M., & Zhao, J. (2026). Circadian rhythm disruption-related genes as potential diagnostic biomarkers in diabetic nephropathy: Integrated transcriptomic, single-nucleus, and molecular docking analyses. Letters in Drug Design & Discovery, 23(9), 100605. https://doi.org/10.1016/j.lddd.2026.100605

Vancouver

Zhou M, Chen X, Chen M, Zhao J. Circadian rhythm disruption-related genes as potential diagnostic biomarkers in diabetic nephropathy: Integrated transcriptomic, single-nucleus, and molecular docking analyses. Letters in Drug Design & Discovery. 2026;23(9):100605. doi:10.1016/j.lddd.2026.100605

BibTeX
@article{Zhou2026,
  author = {Zhou, Min and Chen, Xuan and Chen, Min and Zhao, Jinwen},
  title = {Circadian rhythm disruption-related genes as potential diagnostic biomarkers in diabetic nephropathy: Integrated transcriptomic, single-nucleus, and molecular docking analyses},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {9},
  pages = {100605},
  doi = {10.1016/j.lddd.2026.100605}
}
Kostenlos starten →